Invesco’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Sell |
1,684,099
-8,196,427
| -83% | -$92.4M | ﹤0.01% | 1461 |
|
|
2025
Q1 | $99.7M | Buy |
9,880,526
+365,468
| +4% | +$3.69M | 0.02% | 802 |
|
|
2024
Q4 | $113M | Buy |
9,515,058
+3,159,603
| +50% | +$37.4M | 0.02% | 780 |
|
|
2024
Q3 | $73.3M | Buy |
6,355,455
+447,390
| +8% | +$5.16M | 0.01% | 893 |
|
|
2024
Q2 | $62.4M | Buy |
5,908,065
+5,404,496
| +1,073% | +$57.1M | 0.01% | 924 |
|
|
2024
Q1 | $5.31M | Sell |
503,569
-424,479
| -46% | -$4.47M | ﹤0.01% | 2193 |
|
|
2023
Q4 | $10.4M | Sell |
928,048
-451,937
| -33% | -$5.08M | ﹤0.01% | 1789 |
|
|
2023
Q3 | $16.1M | Buy |
1,379,985
+47,547
| +4% | +$555K | ﹤0.01% | 1455 |
|
|
2023
Q2 | $13.4M | Buy |
1,332,438
+594,416
| +81% | +$5.99M | ﹤0.01% | 1595 |
|
|
2023
Q1 | $5.45M | Buy |
738,022
+237,234
| +47% | +$1.75M | ﹤0.01% | 2173 |
|
|
2022
Q4 | $4M | Buy |
500,788
+485,917
| +3,268% | +$3.88M | ﹤0.01% | 2352 |
|
|
2022
Q3 | $48K | Sell |
14,871
-318
| -2% | -$1.03K | ﹤0.01% | 3895 |
|
|
2022
Q2 | $62K | Buy |
+15,189
| New | +$62K | ﹤0.01% | 3920 |
|